When the FDA approved two gene therapies for sickle cell disease on the same day, adjectives like “momentous” were wheeled out. While the approvals were certainly landmarks, the commercialization that follows may disappoint.
Two weeks before the Christmas holidays, the FDA approved two gene therapies for sickle cell disease (SCD) – an inherited...